SUSPENSION LETTER - MAILED
mailed
on 10 Apr 2024
Last Applicant/ Owned by
36 Toronto Street, Suite 1170
Toronto
CA
M5C2C5
Serial Number
97229628 filed on 20th Jan 2022
Registration Number
N/A
Filing Basis
No Filing Basis
Disclaimer
NO DATA
DIAMOND THERAPEUTICS
Psychedelic-based pharmaceutical research and development for humans; psychedelic-based pharmaceutical drug development for humans; psychedelic-based pharmaceutical research and development in the field of mental health treatments for humans; psychedelic-based drug discovery services for humans; consultancy pertaining to pharmacology in the field of psychedelic-based mental health treatments in hu Read More
Classification Information
Class [040]
Treatment & Processing of Materials Services
Custom manufacture for others of psychedelic-based pharmaceuticals, pharmaceutical drugs, therapeutic pharmaceuticals, and health care products namely, central nervous system health care products used to improve, treat, and prevent mental health diseases, disorders, conditions, and ailments in humans; Custom manufacture for others of psychedelic-based pharmaceuticals, drugs, therapeutic pharmaceuticals, and health care products used to treat mental conditions, illnesses, and disorders in humans
Class [041]
Education and Entertainment Services
Education services, namely providing computer training for brain and neural activity, providing information regarding psychiatric therapies and pharmacology in the field of psychedelic-based mental health treatments for humans
Class [045]
Personal & Legal & Social Services
Licensing of proprietary information in the field of psychedelic-based pharmaceuticals, drugs, therapies, and health care products used to improve, treat, and prevent mental health diseases, disorders, conditions, illnesses, and ailments
Class [042]
Computer & Software Services & Scientific Services
Psychedelic-based pharmaceutical research and development for humans; psychedelic-based pharmaceutical drug development for humans; psychedelic-based pharmaceutical research and development in the field of mental health treatments for humans; psychedelic-based drug discovery services for humans; consultancy pertaining to pharmacology in the field of psychedelic-based mental health treatments in humans; psychedelic-based medical research in the field of human mental health conditions, illnesses, and disorders; neuropsychiatric drug discovery services including pre-clinical and clinical pharmaceutical psychedelic-based drug development for humans; psychedelic-based pharmaceutical drug development and discovery including new chemical entities, neurogenerative drugs, serotonin receptor agonists and antagonist, abuse deterrent drugs, and pharmaceutical preparations for managing a mental, a behavioral, or a neuropsychiatric condition, or its symptoms in humans
Class [039]
Transportation & Storage Services
Warehousing services, namely, distribution of psychedelic-based pharmaceuticals, pharmaceutical drugs, therapeutic pharmaceuticals, and health care products, namely, central nervous system health care products used to improve, treat, and prevent diseases, disorders, conditions, and ailments in humans; Distribution services, namely, delivery of psychedelic-based pharmaceuticals, pharmaceutical drugs, therapeutic pharmaceuticals, and health care products, namely, central nervous pharmaceuticals, pharmaceutical drugs, therapeutic pharmaceuticals, and health care products, namely, central nervous system health care products used to improve, treat, and prevent diseases, disorders, conditions, and ailments in humans
Class [035]
Advertising, Business & Retail Services
Wholesale distributorship featuring psychedelic-based pharmaceuticals, drugs, therapeutic pharmaceuticals, and health care products used to improve, treat, and prevent diseases, disorders, conditions, and ailments in humans; developing marketing strategies for others in the field of psychedelic-based pharmaceuticals, drugs, and health care products used to improve, treat and prevent diseases, disorders, conditions, and ailments in humans; wholesale distributorship featuring distribution and sale of psychedelic-based pharmaceuticals, drugs, therapeutic pharmaceuticals, and health care products used to treat mental conditions, illnesses, and disorders in humans; developing marketing strategies for others in the field of psychedelic-based pharmaceuticals, drugs, therapeutic pharmaceuticals, and health care products used to treat mental conditions, illnesses, and disorders in humans
Class [010]
Medical Instrument Products
Electroencephalogram (EEG) devices namely electroencephalography (EEG) device comprising a sensor for monitoring and measuring brain and neural activity for medical diagnostic purposes during use of psychedelic-based pharmaceuticals, pharmaceutical preparations and products in humans; medical devices for monitoring, sensing, measuring, and training brain and neural activity; medical devices in the nature of elecroencephalogram (EEG), electrocardiogram (EKG), magnetoencephalogram (MEG), functional near-infrared spectroscopy (fNRIS), positron emission tomography (PET), transcranial functional ultrasound, imaging devices, pupillometers, voltmeters, photodiodes, complementary metal-oxide semiconductor (CMOS), ultrasound, piezoelectric resonant devices, lead zirconate titanate (PZT), capacitive micromachined ultrasonic transducer (CMUT), micromembrane ultrasound transducer (PMUT), auditory stimulating devices, visual stimulating devices, sleep monitoring devices, thermometers, heart monitors, blood pressure monitors for use in therapy of cognitive states to monitor, sense, or measure cognitive impairment during use of psychedelic-based pharmaceuticals, pharmaceutical preparations and products in humans; medical devices for stimulating nerves during use of psychedelic-based pharmaceuticals, pharmaceutical preparations and products in humans; medical device used for treating of mental health disorders noninvasively, namely, nodes, headsets, eyewear, probes, computers, tablets, hand-held, mobile and smart phones, smart watches, wrist monitors, body monitors, including implants, body bands, rings and sleeves, fitness trackers for monitoring, sensing, stimulating, measuring, and training brain and neural activity during use of psychedelic-based pharmaceuticals, pharmaceutical preparations and products in humans; tamper resistant dosage dispensers for administering psychedelic-based medicine to human patients
Class [009]
Computer & Software Products & Electrical & Scientific Products
Downloadable computer applications for monitoring, sensing, stimulating, measuring, and training brain and neural activity during use of psychedelic-based pharmaceuticals, pharmaceutical preparations and products in humans; downloadable computer applications for use in therapy of cognitive states during use of psychedelic-based pharmaceuticals, pharmaceutical preparations and products in humans; downloadable computer software applications for monitoring, sensing, stimulating, measuring, and training brain and neural activity during use of psychedelic-based pharmaceuticals, pharmaceutical preparations and products in humans; downloadable computer software applications for use in therapy of cognitive states during use of psychedelic-based pharmaceuticals, pharmaceutical preparations and products in humans; medical systems comprising software and/or hardware for monitoring, sensing, stimulating, measuring, and training brain and neural activity during use of psychedelic-based pharmaceuticals, pharmaceutical preparations and products in humans; medical systems comprising software and/or hardware for use in therapy of cognitive states during use of psychedelic-based pharmaceuticals, pharmaceutical preparations and products in humans; downloadable software as a Medical Device (SaMD) for monitoring, sensing, stimulating, measuring, and training brain and neural activity during use of psychedelic-based pharmaceuticals, pharmaceutical preparations and products in humans; downloadable software as a Medical Device (SaMD) for use in therapy of cognitive states during use of psychedelic-based pharmaceuticals, pharmaceutical preparations and products in humans; downloadable software as a Medical Device (SaMD) for stimulating nerves during use of psychedelic-based pharmaceuticals, pharmaceutical preparations and products in humans
Class [005]
Pharmaceutical Products
Psychedelic-based pharmaceuticals, pharmaceutical preparations and products for the treatment of central nervous system conditions, illnesses, and disorders in humans; psychedelic-based medicines for the treatment of central nervous system conditions, illnesses, and disorders; neurogenerative psychedelic-based pharmaceutical drugs for use in humans; serotonin receptor agonists and antagonist pharmaceutical drugs for use in humans; abuse deterrent products, namely, very low-dose, low dose, and extended release psychedelic-based pharmaceutical preparations to avoid overdosing or diversion of psychedelic drugs; psychedelic-based pharmaceutical preparations for managing a mental, a behavioral, or a neuropsychiatric condition, or its symptoms, namely, motivation, attention, accuracy, response speed, perseverance, cognitive engagement, executive function, mood, behavior; therapeutics for the treatment of mental conditions, illnesses, and disorders in humans
Mark Details
Serial Number
No 97229628
Mark Type
No Service Mark
Attorney Docket Number
No 3496-028.TM
44D Filed
Yes
44D Current
Yes
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 10th Apr 2024 | SUSPENSION LETTER WRITTEN |
| 10th Apr 2024 | LETTER OF SUSPENSION E-MAILED |
| 10th Apr 2024 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| 01st Mar 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 01st Mar 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 01st Mar 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 16th Jan 2024 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| 16th Jan 2024 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| 16th Oct 2023 | NON-FINAL ACTION WRITTEN |
| 16th Oct 2023 | NON-FINAL ACTION E-MAILED |